Acute exacerbation affects prognosis in RA-associated interstitial lung diseaseFebruary 24, 2022Rheumatoid Arthritis
More evidence supporting ultra-low retreatment dose of rituximab in RAFebruary 24, 2022Rheumatoid Arthritis
Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitorsFebruary 24, 2022Rheumatoid Arthritis
Rheumatology NewsTwenty-three percent of health care workers likely to leave industry soon: PollFebruary 24, 2022Business of MedicineCOVID-19 Updates
PsA: TNF-blockade does not downregulate IL-17 cytokine and receptor protein levelFebruary 23, 2022Psoriatic Arthritis
Sex-specific adjustments in management strategy may be beneficial in early PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Patients have high anxiety levels that decline after initiation of biologicsFebruary 23, 2022Psoriatic Arthritis
MIC of PASDAS could serve as an additional tool to understand patients’ perspectives of PsAFebruary 23, 2022Psoriatic Arthritis
Doppler signals and bone erosions at enthesis indicate more severe PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Time to clinically meaningful response shorter with tofacitinib vs. placeboFebruary 23, 2022Psoriatic Arthritis
